Entheon Biomedical Corp.
ENTBF
$0.08
-$0.001-1.24%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.81% | 94.98% | 93.86% | 95.89% | 96.55% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -100.10% | -99.95% | -99.84% | -100.05% |
| Change in Net Operating Assets | 34.89% | -99.08% | 79.58% | 129.17% | -112.90% |
| Cash from Operations | 2.32% | 25.52% | -202.20% | 73.00% | 82.59% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -98.30% | -95.37% | -96.03% | -95.83% |
| Cash from Investing | -- | -98.30% | -95.37% | -96.03% | -95.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 135.31% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -202.20% | -- | -- |
| Net Change in Cash | 38.69% | -215.29% | -1,535.00% | 33.06% | 77.20% |